Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results
Go back to Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.10 -0.07 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $16.89 | |||
| Open | $4.14 | 52 Week Low | $7.35 | |||
| Day High | $4.16 | P/E | N/A | |||
| Day Low | $4.04 | EPS | $-2.35 | |||
| Volume | 714,197 | |||||
